Guardant Health (GH) Current Deferred Revenue (2017 - 2026)

Guardant Health has disclosed Current Deferred Revenue across 10 years of filings, most recently posting $56.7 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $56.7 million, up 28.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.7 million (up 28.86% YoY), and the FY2025 annual result was $50.8 million, up 22.0% from the prior year.
• Current Deferred Revenue came in at $56.7 million for Q1 2026 at Guardant Health, up from $50.8 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $60.7 million in Q2 2025 to a low of $10.6 million in Q1 2022.
• The 5-year median for Current Deferred Revenue is $27.8 million (2024), against an average of $31.2 million.
• Across the five-year window, Current Deferred Revenue soared 110.47% in 2022 and slipped 12.72% in 2023, its largest moves.
• Guardant Health's Current Deferred Revenue stood at $17.4 million in 2022, then jumped by 31.59% to $22.9 million in 2023, then soared by 81.66% to $41.6 million in 2024, then rose by 22.0% to $50.8 million in 2025, then climbed by 11.72% to $56.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $56.7 million (Q1 2026), $50.8 million (Q4 2025), and $46.9 million (Q3 2025), per Business Quant data.